A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.

NCT07412236 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1208

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Fibrosis
Liver Fibrosis in Chronic Hepatitis B

Interventions

DRUG: Hydronidone (270mg)
DRUG: Hydronidone (Placebo Group)

Sponsor

Beijing Continent Pharmaceutical Co, Ltd.

Collaborators

[object Object]